Timothy W. James is listed as an executive officer and director on 14 SEC Form D filings by 1 issuer between Mar 2019 and Apr 2026: bioProtonics, Inc. (Santa Barbara, CA — industry reported as "Other" — 2019–2026; $2.7M reported sold to 18 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Kristin Loomis (14 shared filings), Daniel R. Doiron (13 shared filings), Forrest Fleming (7 shared filings), Ryan Shields (4 shared filings), Charles W Winckler (2 shared filings) and 4 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Timothy. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 14 public filings for Timothy W. James and found 7 differences: Timothy W. James's role changed at bioProtonics, Inc.: executive officer, director → director; 4 offerings changed their target amount between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.